首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Molecular oncology

缩写:MOL ONCOL

ISSN:1574-7891

e-ISSN:1878-0261

IF/分区:4.5/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引2661
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Matteo Arnaudi,Karolina Krzesińska,Ludovica Beltrame et al. Matteo Arnaudi et al.
Genetic variants in the DNA polymerase enzymes POLE and POLD1 can affect protein function by altering stability, catalysis, DNA binding, and interactions with other biomolecules. Understanding the structural basis of these variants is impor...
Dimitra Stergiopoulou,Athina Markou,Eleonora Nicolo et al. Dimitra Stergiopoulou et al.
Endocrine resistance is a complex phenomenon, including alterations of the ESR1 gene. The aim of this study was to simultaneously analyze ESR1 promoter methylation and ESR1 hotspot mutations in circulating tumor cells (CTCs) and paired plas...
Kamila J Bienkowska,Stephany Gallardo,Nur S Zainal et al. Kamila J Bienkowska et al.
Cellular plasticity is central to non-small cell lung cancer (NSCLC) disease progression and linked to aberrant regulation of developmental programmes. Here, we investigated the contribution of two developmental programmes, alveogenesis (AL...
Patryk Rurka,Wioleta Cieślik,Wojciech Płaziński et al. Patryk Rurka et al.
Aberrant signaling through insulin-like growth factor 1 receptor (IGF1R) and epidermal growth factor receptor (EGFR) drives glioblastoma (GBM) progression and therapy resistance. Herein, we describe the synthesis and biological evaluation o...
Jun Xu,Nicolas J Niklaus,Anna M Schläfli et al. Jun Xu et al.
The cyclin D binding Myb-like Transcription Factor 1 (DMTF1) is a haploinsufficient tumor suppressor in various tumors. Alternative splicing generates a dominant negative, truncated version of full-length DMTF1α, named DMTF1β. DMTF1β has...
Jun Nishimura,Tadahiro Kuribayashi,Johannes Brägelmann et al. Jun Nishimura et al.
Epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancers (NSCLCs) lack effective immunotherapy due to a noninflamed tumor microenvironment (TME). We previously reported that EGFR tyrosine-kinase-inhibitor (TKI) induced CD8...
Radhika Sain,Yann Le Page,Frédéric Percevault et al. Radhika Sain et al.
The 3'-5' exoribonuclease EXOSC10 degrades aberrant mRNAs and noncoding RNAs in cooperation with the nuclear RNA exosome. EXOSC10's localization and stability are regulated by sumoylation and proteasomal degradation in response to stress, a...
Amelie S Schober,Leire Moreno-Cugnon,Laura Martínez-Pérez et al. Amelie S Schober et al.
Oxygen availability is frequently compromised in solid tumours, making intratumoural hypoxia a common feature of cancer. In prostate cancer (PCa), hypoxia is strongly associated with aggressive disease and poor prognosis. Hypoxia-inducible ...
Matthew O Ellis,Jack V Mills,Wojciech Niedzwiedz et al. Matthew O Ellis et al.
The insulin-like growth factor (IGF) axis regulates cancer cell proliferation, growth, invasion, and therapy resistance. Elevated expression of the type 1 IGF receptor (IGF-1R) is linked to radioresistance and biochemical recurrence in pros...